SECONDARY GOUT ASSOCIATED WITH CHRONIC MYELOPROLIFERATIVE DISORDERS.TS'AI FAN YU; WEINREB N; WITTMAN R et al.1976; SEMINARS ARTHRITIS RHEUMATISM; U.S.A.; DA. 1976; VOL. 5; NO 3; PP. 247-256; BIBL. 21 REF.Article

Short-Term Repeatability of Diurnal Intraocular Pressure Patterns in Glaucomatous IndividualsREALINI, Tony; WEINREB, N; WISNIEWSKI, Stephen et al.Ophthalmology (Rochester, MN). 2011, Vol 118, Num 1, pp 47-51, issn 0161-6420, 5 p.Article

Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease : An analysis of 798 patients from the ICGG Gaucher RegistryFAIRLEY, C; ZIMRAN, A; PHILLIPS, M et al.Journal of inherited metabolic disease. 2008, Vol 31, Num 6, pp 738-744, issn 0141-8955, 7 p.Article

Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease : results of a 48-month longitudinal cohort studySIMS, K. B; PASTORES, G. M; FITZPATRICK, M. A et al.Clinical genetics. 2008, Vol 73, Num 5, pp 430-440, issn 0009-9163, 11 p.Article

Response of Gaucher bone disease to enzyme replacement therapyPOLL, L. W; MAAS, M; TERK, M. R et al.British journal of radiology. 2002, Vol 75, pp A25-A36, issn 0007-1285, SUP1Conference Paper

Gaucher disease : Recommendations on diagnosis, evaluation, and monitoringCHARROW, J; ESPLIN, J. A; GRIBBLE, T. J et al.Archives of internal medicine (1960). 1998, Vol 158, Num 16, pp 1754-1760, issn 0003-9926Article